CRAB Provides Several Types of Training to Clinical Professionals

Clinical Site Training

  • Electronic data capture (EDC) user training, electronic case report form (eCRF) Completion Guidelines
  • Site Initiation Visits
  • Protocol Adherence Training

Training is customized to the requirements of each clinical trial and can be conducted at Investigator Meetings, on-site or via webinar.

After the study is begun, our project managers, data managers and monitors work together with the clients to help them understand and utilize the research systems to their fullest capacity.

Investigator and Statistical Training

CRAB is committed to training investigators, clinical research associates, and biostatisticians in the conduct of oncology trials. Professionals at CRAB have continued a training tradition established by founder John Crowley, PhD, who has been instrumental in development of training workshops within SWOG and with other sponsors such as ASCO and AACR. CRAB provides customized training modeled after these national programs.

SWOG Young Investigators Training Course
Every year 4-8 Young Investigators are chosen by SWOG to participate in a 3 day workshop patterned after the ASCO/AACR Vail course. Each participant comes with a protocol sysnopsis approved by the appropriate SWOG committee chairs, and leaves with a nearly final protocol, including a detailed statistical section, for implementation in SWOG.

SWOG Clinical Trial Training Course
The Clinical Trials Training Course introduces the fundamentals of SWOG and National Cancer Institute (NCI) policies and procedures to new Clinical Research Associates (CRAs). It provides the foundation to efficiently perform responsibilities as a CRA.

Customized Clinical Trials Training
CRAB has provided customized clinical trials training courses for the Cancer Treatment Centers of America, and for investigators at the OHSU Knight Cancer Institute. We have also taught a cancer clinical trials course ot the University of Washington Summer Biostatistics Institute.

Photo of Human colorectal cancer cells
Human colorectal cancer cells treated with a topoisomerase inhibitor and an inhibitor of the protein kinase ATR (ataxia telangiectasia and Rad3 related), a drug combination under study as a cancer therapy. Cell nuclei are stained blue; the chromosomal protein histone gamma-H2AX marks DNA damage in red and foci of DNA replication in green. Created by Yves Pommier, Rozenn Josse, 2014

CRAB often presents at scientific meetings such as American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), World Lung Cancer Conference, Breast Cancer Symposia, American Society of Prevenative Oncology (ASPO), Society for Clinical Trials (SCT), Society of Clinical Research Associates (SOCRA), and Model Agreements & Guidelines International (MAGI). Watch for CRAB scientists at these venues and track our plans and progress in the News and Events section of our website.